Skip to main content
. 2024 Apr 22;20(6):3918–3930. doi: 10.1002/alz.13838

FIGURE 4.

FIGURE 4

Changes in composite score from baseline at 18‐month follow‐up according to dementia‐related plasma biomarkers in full‐analysis set. *Mean difference in changes in composite score between intervention and control groups was significant (p < 0.05). Aβ, amyloid beta; GFAP, glial fibrillary acidic protein; NfL, neurofilament light chain; p‐tau181, tau phosphorylated at threonine 181.